The Deal by S&P Global

Monogram Capital co-founder and partner Jared Stein talks about finding upstart consumer brands, the firm's investment criteria and cutting through the noise to find long-term trends.

Gavriel Kahane, co-founder of the real estate-focused private equity firm Arkhouse Partners, talks about activism within a market that is experiencing 'rapacious private demand.'

UC Berkeley professor Carolyn Chen discusses her new book 'Work Pray Code: When Work Becomes Religion in Silicon Valley,' in which she argues that companies have replaced religious institutions as sources of meaning and identity for white-collar Americans.  

Lazard’s Jim Rossman, a top corporate defender and banker, explains why a new disclosure rule is a 'big win' for companies while changes to proxy contest rules will open the floodgates to activists nominating director candidates.

Kirkland debt finance partner Eric Wedel discusses the evolution of the practice and how the emergence of capital markets desks at PE sponsors have changed it in this week's podcast. 

Wachtell Lipton’s David Katz, a top corporate defender, explains why he is excited that the nation’s securities regulator just issued new tougher transparency rules for activists.

Kimberly Smith, head of Katten's corporate department, discusses the current state of middle-market dealmaking, her work with family offices and increased regulatory scrutiny of even smaller deals. 

Justin Savage, co-head of the environmental and automotive and mobility groups at Sidley Austin, discusses his unconventional path to law firm practice, what he learned at the DOJ and how he talks to boards and management teams about environmental issues.

Ann Chung and Kelley Morrell, managing directors at Blackstone, take a deep dive into the firm's stake in the popular shapewear brand Spanx, the private equity giant's approach to investments and more.

Covington head of M&A and corporate Catherine Dargan discussed building her healthcare M&A practice, current issues in healthcare dealmaking and her approaches to diversity and inclusion and associate retention in this week's podcast. 

Eduardo Gallardo, co-chair of M&A and chair of the activist defense group at Gibson Dunn, discussed the universal proxy, the Williams case and more on this week's Drinks With The Deal podcast.

Scott Mushkin, a consumer-focused researcher, discussed Mantle Ridge’s contest at Dollar Tree and compared the discount retailer’s new pricing strategy to Coca-Cola’s failed ‘New Coke’ endeavor.

 Greg Varallo, partner at Bernstein Litowitz in Wilmington, discussed the switch from representing companies to working with shareholders, Andy Bouchard's achievements as Chancellor, his love of hunting, poker and the American University of Rome and more in this week's episode of the podcast. 

Tariq Mundiya, the head of litigation at Willkie Farr & Gallagher, discusses the Williams poison pill case from earlier this year as well as the CytoDyn decision and the evolution of Delaware's Caremark doctrine in this week's Drinks With The Deal podcast.

James 'Jim' Barresi, who heads the financial services practice at Squire Patton Boggs, explains how his time as an in-house lawyer at US Bancorp in the 1990s has shaped his approach to private practice and how he works with clients who are considering a deal.

On the latest edition of Drinks With The Deal, David Wondrich and Noah Rothbaum discuss their work editing the new Oxford Companion to Spirits and Cocktails, which considers at length the companies, entrepreneurs and trends that have driven the alcohol business.  

Ed Zimmerman discusses building the tech group at Lowenstein Sandler and his commitment to social justice on the latest Drinks With The Deal podcast.

Professor Melissa Jacoby of University of North Carolina at Chapel Hill discusses the limits of bankruptcy in handling mass tort cases and the recent filings of Purdue Pharma LP and others on the latest episode of the Fresh Start podcast.

M&A lawyer Krishna Veeraraghavan talks about health care M&A and the risks of excessive antitrust regulation of combinations between biotech and pharma companies in the Drinks With The Deal podcast.

Matt Simpson of Mintz Levin discussed his transition from peace negotiator to M&A lawyer, why he enjoys the middle market, what he's learned from advising reps and warranties insurers and how he finds serenity on sailboats in the latest edition of Drinks With The Deal.  

EQT Growth head Marc Brown said EQT's desire as a firm to do well financially while promoting diversity and inclusion appealed to him as he looked to start a new phase of his career after 20 years working on M&A deals at Microsoft.

Moelis' Duncan Herrington spoke with the Activist Investing Today podcast about proxy advisers and corporate director selection efforts following ESG activist Engine No. 1's big win at Exxon Mobil. 

Rob Jackson, a former SEC commissioner and current NYU Law professor, and John Morley, a professor at Yale Law School, said SPACs should be treated more stringently by the SEC and discussed their current research projects during the latest Drinks With The Deal podcast. 

Hilco Global president Ian Fredericks discusses the business of liquidation and the outlook for retail on this week’s Fresh Start podcast.

Brian Stafford, CEO of the governance risk and compliance software provider Diligent Corp., explains why he thinks boards are reevaluating their membership in the wake of Engine No. 1’s surprising ESG victory at Exxon Mobil.